tradingkey.logo

H&F weighs $9 billion-plus sale of medical device maker Cordis, Bloomberg News reports

ReutersJan 17, 2026 2:19 AM

- U.S. private equity firm Hellman & Friedman is in early-stage talks for a potential sale of medical devices maker Cordis, seeking a value of over $9 billion, Bloomberg News reported on Friday, citing people familiar with the matter.

About half a dozen publicly traded medical device companies are currently evaluating potential bids for Cordis, the report added.

Hellman & Friedman bought Cordis from Cardinal Health in 2021 for about $1 billion, six years after Johnson & Johnson JNJ.N sold it.

Cordis is known for making cardiovascular devices such as catheters and stents.

H&F and KKR KKR.N, an investor in Cordis, declined to comment. Cordis did not immediately respond to Reuters' requests for comment outside of regular business hours.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI